{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:23:15Z","timestamp":1791404595290,"version":"4.3.3"},"reference-count":33,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"CAMS Initiative for Innovative Medicine","award":["2016-I2M-1-017"],"award-info":[{"award-number":["2016-I2M-1-017"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81330015"],"award-info":[{"award-number":["81330015"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81500098"],"award-info":[{"award-number":["81500098"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.jcyt.2017.11.006","type":"journal-article","created":{"date-parts":[[2017,12,18]],"date-time":"2017-12-18T18:46:00Z","timestamp":1513622760000},"page":"181-188","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"title":["Exosomes from mesenchymal stromal cells enhance imatinib-induced apoptosis in human leukemia cells via activation of caspase signaling pathway"],"prefix":"10.1016","volume":"20","author":[{"given":"Ying","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoquan","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yimeng","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huifang","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongjin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongchao","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengxia","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jcyt.2017.11.006_bib0010","doi-asserted-by":"crossref","first-page":"541","DOI":"10.3324\/haematol.2015.139337","article-title":"Chronic myeloid leukemia: reminiscences and dreams","volume":"101","author":"Mughal","year":"2016","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.jcyt.2017.11.006_bib0015","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1586\/14737140.2016.1151356","article-title":"Imatinib mesylate in chronic myeloid leukemia: frontline treatment and long-term outcomes","volume":"16","author":"Stagno","year":"2016","journal-title":"Expert Rev Anticancer Ther"},{"issue":"23","key":"10.1016\/j.jcyt.2017.11.006_bib0020","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1056\/NEJMoa062867","article-title":"Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia","volume":"355","author":"Druker","year":"2006","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.jcyt.2017.11.006_bib0025","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/MOH.0000000000000224","article-title":"Is cure for chronic myeloid leukemia possible in the tyrosine kinase inhibitors era?","volume":"23","author":"Bansal","year":"2016","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.jcyt.2017.11.006_bib0030","doi-asserted-by":"crossref","first-page":"734731","DOI":"10.1155\/2015\/734731","article-title":"Stem cells and regenerative medicine: myth or reality of the 21th century","volume":"2015","author":"Stoltz","year":"2015","journal-title":"Stem Cells Int"},{"issue":"12","key":"10.1016\/j.jcyt.2017.11.006_bib0035","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.3727\/096368915X687462","article-title":"Human umbilical cord mesenchymal stem cells promote breast cancer metastasis by interleukin-8- and interleukin-6-dependent induction of CD44(+)\/CD24(\u2212) cells","volume":"24","author":"Ma","year":"2015","journal-title":"Cell Transplant"},{"issue":"1","key":"10.1016\/j.jcyt.2017.11.006_bib0040","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.canlet.2009.02.022","article-title":"Human mesenchymal stem cells (hMSCs) target osteosarcoma and promote its growth and pulmonary metastasis","volume":"281","author":"Xu","year":"2009","journal-title":"Cancer Lett"},{"issue":"4","key":"10.1016\/j.jcyt.2017.11.006_bib0045","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/cr.2008.40","article-title":"Suppression of tumorigenesis by human mesenchymal stem cells in a hepatoma model","volume":"18","author":"Qiao","year":"2008","journal-title":"Cell Res"},{"issue":"4","key":"10.1016\/j.jcyt.2017.11.006_bib0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0010350","article-title":"Upregulation of PTEN in glioma cells by cord blood mesenchymal stem cells inhibits migration via downregulation of the PI3K\/Akt pathway","volume":"5","author":"Dasari","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jcyt.2017.11.006_bib0055","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1089\/scd.2012.0621","article-title":"Mesenchymal stem cells induce granulocytic differentiation of acute promyelocytic leukemic cells via il-6 and MEK\/ERK pathways","volume":"22","author":"Chen","year":"2013","journal-title":"Stem Cells Dev"},{"issue":"6","key":"10.1016\/j.jcyt.2017.11.006_bib0060","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1159\/000323973","article-title":"p38 MAPK contributes to the growth inhibition of leukemic tumor cells mediated by human umbilical cord mesenchymal stem cells","volume":"26","author":"Tian","year":"2010","journal-title":"Cell Physiol Biochem"},{"issue":"5","key":"10.1016\/j.jcyt.2017.11.006_bib0065","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1038\/leu.2008.384","article-title":"Human mesenchymal stem cells inhibit cancer cell proliferation by secreting DKK-1","volume":"23","author":"Zhu","year":"2009","journal-title":"Leukemia"},{"issue":"7","key":"10.1016\/j.jcyt.2017.11.006_bib0070","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.3324\/haematol.2009.017178","article-title":"Bone marrow mesenchymal stromal cells non-selectively protect chronic myeloid leukemia cells from imatinib-induced apoptosis via the CXCR4\/CXCL12 axis","volume":"95","author":"Vianello","year":"2010","journal-title":"Haematologica"},{"issue":"19","key":"10.1016\/j.jcyt.2017.11.006_bib0075","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1182\/blood-2014-05-576421","article-title":"Tyrosine kinase inhibitors induce mesenchymal stem cell-mediated resistance in BCR-ABL+ acute lymphoblastic leukemia","volume":"125","author":"Mallampati","year":"2015","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.jcyt.2017.11.006_bib0080","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nrd3978","article-title":"Extracellular vesicles: biology and emerging therapeutic opportunities","volume":"12","author":"El Andaloussi","year":"2013","journal-title":"Nat Rev Drug Discov"},{"issue":"6","key":"10.1016\/j.jcyt.2017.11.006_bib0085","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.cell.2016.01.043","article-title":"Communication by extracellular vesicles: where we are and where we need to go","volume":"164","author":"Tkach","year":"2016","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.jcyt.2017.11.006_bib0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0084256","article-title":"Exosomes derived from mesenchymal stem cells suppress angiogenesis by down-regulating VEGF expression in breast cancer cells","volume":"8","author":"Lee","year":"2013","journal-title":"PLoS ONE"},{"issue":"4","key":"10.1016\/j.jcyt.2017.11.006_bib0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0061366","article-title":"Microvesicles derived from human umbilical cord Wharton's jelly mesenchymal stem cells attenuate bladder tumor cell growth in vitro and in vivo","volume":"8","author":"Wu","year":"2013","journal-title":"PLoS ONE"},{"issue":"15","key":"10.1016\/j.jcyt.2017.11.006_bib0100","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1080\/15384101.2015.1005530","article-title":"Exosomes derived from human mesenchymal stem cells confer drug resistance in gastric cancer","volume":"14","author":"Ji","year":"2015","journal-title":"Cell Cycle"},{"issue":"4","key":"10.1016\/j.jcyt.2017.11.006_bib0105","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1182\/blood-2014-03-562439","article-title":"Bone marrow stromal cell-derived exosomes as communicators in drug resistance in multiple myeloma cells","volume":"124","author":"Wang","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2017.11.006_bib0110","doi-asserted-by":"crossref","first-page":"23978","DOI":"10.1038\/srep23978","article-title":"ExtraPEG: a polyethylene glycol-based method for enrichment of extracellular vesicles","volume":"6","author":"Rider","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jcyt.2017.11.006_bib0115","author":"Antes"},{"key":"10.1016\/j.jcyt.2017.11.006_bib0120","doi-asserted-by":"crossref","first-page":"1384e92","DOI":"10.1634\/stemcells.2006-0709","article-title":"Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow","volume":"25","author":"Baksh","year":"2007","journal-title":"Stem Cells"},{"issue":"5","key":"10.1016\/j.jcyt.2017.11.006_bib0125","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1089\/ten.teb.2013.0664","article-title":"Umbilical cord mesenchymal stem cells: the new gold standard for mesenchymal stem cell-based therapies?","volume":"20","author":"El Omar","year":"2014","journal-title":"Tissue Eng Part B Rev"},{"key":"10.1016\/j.jcyt.2017.11.006_bib0130","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3389\/fonc.2016.00125","article-title":"Cross talk between cancer and mesenchymal stem cells through extracellular vesicles carrying nucleic acids","volume":"6","author":"Lopatina","year":"2016","journal-title":"Front Oncol"},{"issue":"3","key":"10.1016\/j.jcyt.2017.11.006_bib0135","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.exphem.2013.11.006","article-title":"Single-cell analysis of K562 cells: an imatinib-resistant subpopulation is adherent and has upregulated expression of BCR-ABL mRNA and protein","volume":"42","author":"Karimiani","year":"2014","journal-title":"Exp Hematol"},{"issue":"3","key":"10.1016\/j.jcyt.2017.11.006_bib0140","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.tice.2015.01.005","article-title":"Human Wharton's jelly mesenchymal stem cell secretome display antiproliferative effect on leukemia cell line and produce additive cytotoxic effect in combination with doxorubicin","volume":"47","author":"Hendijani","year":"2015","journal-title":"Tissue Cell"},{"issue":"9","key":"10.1016\/j.jcyt.2017.11.006_bib0145","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1089\/scd.2012.0486","article-title":"Umbilical cord blood-derived mesenchymal stem cells inhibit, but adipose tissue-derived mesenchymal stem cells promote, glioblastoma multiforme proliferation","volume":"22","author":"Akimoto","year":"2013","journal-title":"Stem Cells Dev"},{"issue":"6","key":"10.1016\/j.jcyt.2017.11.006_bib0150","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1111\/bjh.13551","article-title":"Alterations in acute myeloid leukaemia bone marrow stromal cell exosome content coincide with gains in tyrosine kinase inhibitor resistance","volume":"172","author":"Viola","year":"2016","journal-title":"Br J Haematol"},{"issue":"5","key":"10.1016\/j.jcyt.2017.11.006_bib0155","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/leu.2016.324","article-title":"Molecular alterations in bone marrow mesenchymal stromal cells derived from acute myeloid leukemia patients","volume":"31","author":"von der Heide","year":"2017","journal-title":"Leukemia"},{"issue":"11","key":"10.1016\/j.jcyt.2017.11.006_bib0160","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1134\/S0006297915110012","article-title":"Mechanisms of apoptosis","volume":"80","author":"Savitskaya","year":"2015","journal-title":"Biochemistry Mosc"},{"key":"10.1016\/j.jcyt.2017.11.006_bib0165","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.stem.2012.12.013","article-title":"BCL-2 inhibition targets oxidative phosphorylation and selectively eradicates quiescent human leukemia stem cells","volume":"12","author":"Lagadinou","year":"2013","journal-title":"Cell Stem Cell"},{"issue":"2","key":"10.1016\/j.jcyt.2017.11.006_bib0170","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/ijc.30669","article-title":"The role of exosomes and miRNAs in drug-resistance of cancer cells","volume":"141","author":"Bach","year":"2017","journal-title":"Int J Cancer"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324917307338?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324917307338?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T01:34:00Z","timestamp":1761442440000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324917307338"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S1465324917307338"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2017.11.006","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exosomes from mesenchymal stromal cells enhance imatinib-induced apoptosis in human leukemia cells via activation of caspase signaling pathway","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2017.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 International Society for Cellular Therapy. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}